KEMADRIN Safety Questions, KEMADRIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about KEMADRIN. Our extensive database of KEMADRIN adverse events and KEMADRIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about KEMADRIN
KEMADRIN Safety Reports
Total KEMADRIN reports: 9.KEMADRIN FDA safety alerts: No.
Reported deaths: 5 Reported hospitalizations: 3.
Take KEMADRIN Side Effects Survey or Share Your KEMADRIN Story. KEMADRIN Usage.
Physician from IRELAND reported KEMADRIN problem on Jan 17, 2007. Female patient was diagnosed with dystonia, mental disorder and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cardio-respiratory arrest, dilatation ventricular, vomiting. KEMADRIN dosage: 20 MG, (2 DOSES, 7 HOURS APART). During the same period patient was treated with FLUPHENAZINE DECANOATE, HALOPERIDOL. Patient died on 01/14/2006.
KEMADRIN problem was reported by a Physician from IRELAND on Mar 07, 2007. Female patient was diagnosed with mental disorder and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, cardio-respiratory arrest, dilatation ventricular, pulmonary infarction, right ventricular failure, vomiting. KEMADRIN dosage: 20 MG (2 DOSES 7 HOURS APART). During the same period patient was treated with FLUPHENAZINE DECANOATE, HALOPERIDOL. Patient died on 01/14/2006.
Pharmacist from UNITED KINGDOM reported KEMADRIN problem on July 07, 2006. Female patient was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: agitation, confusional state, overdose. KEMADRIN dosage: 85 MG, SINGLE. Patient recovered.
KEMADRIN problem was reported by a Health Professional from UNITED KINGDOM on July 26, 2006. Female patient, 45 years of age, was diagnosed with psychotic disorder, depression, epilepsy and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: poor personal hygiene, weight increased. KEMADRIN dosage: 10 MG, UNK. During the same period patient was treated with ABILIFY, FEMODENE, SOLIAN, CITALOPRAM HYDROCHLORIDE, KEPPRA, TEGRETOL. Patient died on 06/10/2006.
Physician from UNITED STATES reported KEMADRIN problem on Sept 26, 2006. Male patient, 70 years of age, was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: unevaluable event. KEMADRIN dosage: 25 MG, SINGLE DOSE. During the same period patient was treated with ALBUTEROL SPIROS. Patient was hospitalized. Patient recovered.
KEMADRIN problem was reported by a Physician from IRELAND on Nov 06, 2006. Female patient, 36 years of age, was diagnosed with dystonia and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: blood alcohol increased, cardio-respiratory arrest, dilatation ventricular. KEMADRIN dosage: 2 ML, BID. During the same period patient was treated with FLUPHENAZINE DECANOATE. Patient died on 01/14/2006.
Physician from IRELAND reported KEMADRIN problem on Nov 06, 2006. Female patient, 36 years of age, was diagnosed with dystonia and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: asthenia, blood alcohol increased, cardio-respiratory arrest, dilatation ventricular, pulmonary infarction, vomiting. KEMADRIN dosage: 20 MG, (2 DOSES, 6 HOURS APART). During the same period patient was treated with FLUPHENAZINE DECANOATE, HALOPERIDOL. Patient died on 01/14/2006.
KEMADRIN problem was reported by a Pharmacist from IRELAND on July 31, 2007. Female patient was diagnosed with parkinson's disease and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state. KEMADRIN dosage: 2.5 MG, TID. Patient was hospitalized and became disabled. Patient recovered.
Pharmacist from IRELAND reported KEMADRIN problem on Aug 31, 2007. Female patient was diagnosed with parkinson's disease and was treated with KEMADRIN. After drug was administered, patient experienced the following problems/side effects: amnesia, confusional state, disorientation. KEMADRIN dosage: 2.5 MG, TID. During the same period patient was treated with CARDICOR, COVERSYL, FUROSEMIDE, FERROGRAD. Patient was hospitalized and became disabled. Patient recovered.